These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 17536512

  • 1. [Immunoproteomics of Helicobacter pylori--strategy for improvement of diagnostic tests and vaccine development].
    Roszczenko P, Jagusztyn-Krynicka EK.
    Postepy Biochem; 2006; 52(4):424-34. PubMed ID: 17536512
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori: immunoproteomics related to different pathologies.
    Bernardini G, Braconi D, Lusini P, Santucci A.
    Expert Rev Proteomics; 2007 Oct; 4(5):679-89. PubMed ID: 17941822
    [Abstract] [Full Text] [Related]

  • 3. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C, Ottiwet O, Hahnvajanawong C, Intapan PM, Wongwajana S.
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [Abstract] [Full Text] [Related]

  • 4. Inflammation, immunity and vaccines for Helicobacter pylori.
    Del Giudice G, Michetti P.
    Helicobacter; 2004 Sep; 9 Suppl 1():23-8. PubMed ID: 15347302
    [Abstract] [Full Text] [Related]

  • 5. Immunology of Helicobacter pylori infection.
    Velin D, Michetti P.
    Digestion; 2006 Sep; 73(2-3):116-23. PubMed ID: 16788292
    [Abstract] [Full Text] [Related]

  • 6. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [Abstract] [Full Text] [Related]

  • 7. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A.
    Immunol Invest; 2007 Aug; 36(4):371-86. PubMed ID: 17691020
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype.
    Lahner E, Bernardini G, Santucci A, Annibale B.
    Expert Rev Proteomics; 2010 Apr; 7(2):239-48. PubMed ID: 20377390
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.
    Rossi G, Ruggiero P, Peppoloni S, Pancotto L, Fortuna D, Lauretti L, Volpini G, Mancianti S, Corazza M, Taccini E, Di Pisa F, Rappuoli R, Del Giudice G.
    Infect Immun; 2004 Jun; 72(6):3252-9. PubMed ID: 15155627
    [Abstract] [Full Text] [Related]

  • 10. [Inflammation as a basis for Helicobacter pylori-associated diseases].
    Kononov AV.
    Arkh Patol; 2006 Jun; 68(5):3-10. PubMed ID: 17144521
    [Abstract] [Full Text] [Related]

  • 11. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies.
    Mini R, Bernardini G, Salzano AM, Renzone G, Scaloni A, Figura N, Santucci A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar 20; 833(1):63-79. PubMed ID: 16483854
    [Abstract] [Full Text] [Related]

  • 12. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.
    Chui SY, Clay TM, Lyerly HK, Morse MA.
    Cancer Epidemiol Biomarkers Prev; 2005 Aug 20; 14(8):1883-9. PubMed ID: 16103431
    [Abstract] [Full Text] [Related]

  • 13. Development of a vaccine against Helicobacter pylori infection.
    Michetti P.
    Ital J Gastroenterol Hepatol; 1998 Oct 20; 30 Suppl 3():S339-41. PubMed ID: 10077770
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori immunology and vaccines.
    Vorobjova T, Watanabe T, Chiba T.
    Helicobacter; 2008 Oct 20; 13 Suppl 1():18-22. PubMed ID: 18783517
    [Abstract] [Full Text] [Related]

  • 15. [Organization of the Helicobacter pylori genome].
    Zawilak A, Zakrzewska-Czerwińska J.
    Postepy Hig Med Dosw; 2001 Oct 20; 55(3):355-67. PubMed ID: 11505637
    [Abstract] [Full Text] [Related]

  • 16. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R.
    Annu Rev Immunol; 2001 Oct 20; 19():523-63. PubMed ID: 11244046
    [Abstract] [Full Text] [Related]

  • 17. The current status of Helicobacter pylori vaccines: a review.
    Kabir S.
    Helicobacter; 2007 Apr 20; 12(2):89-102. PubMed ID: 17309745
    [Abstract] [Full Text] [Related]

  • 18. [Helicobacter pylori, 13 years after the original publication].
    Beltrán-Garcíal MJ, Fujii TO.
    Rev Latinoam Microbiol; 1997 Apr 20; 39(1-2):9-31. PubMed ID: 10932712
    [Abstract] [Full Text] [Related]

  • 19. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies.
    Vogiatzi P, Cassone M, Luzzi I, Lucchetti C, Otvos L, Giordano A.
    J Cell Biochem; 2007 Oct 01; 102(2):264-73. PubMed ID: 17486575
    [Abstract] [Full Text] [Related]

  • 20. [Immunologic reactions in infections caused by Helicobacter pylori].
    Chmiela M, Rudnicka W.
    Postepy Hig Med Dosw; 1997 Oct 01; 51(2):115-38. PubMed ID: 9235561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.